As of 2025-12-20, the Relative Valuation of Relay Therapeutics Inc (RLAY) is (30.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.40 USD, the upside of Relay Therapeutics Inc based on Relative Valuation is -462.8%.
The range of the Relative Valuation is (18.58) - (35.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 20.6x | 17.6x |
| Forward P/E multiples | 10.8x - 25.1x | 17.9x |
| Fair Price | (18.58) - (35.44) | (30.48) |
| Upside | -321.2% - -521.9% | -462.8% |
| Date | P/E |
| 2025-12-15 | -4.80 |
| 2025-12-12 | -4.68 |
| 2025-12-11 | -4.54 |
| 2025-12-10 | -4.42 |
| 2025-12-09 | -4.41 |
| 2025-12-08 | -4.44 |
| 2025-12-05 | -4.47 |
| 2025-12-04 | -4.66 |
| 2025-12-03 | -4.56 |
| 2025-12-02 | -4.36 |
| 2025-12-01 | -4.31 |
| 2025-11-28 | -4.61 |
| 2025-11-26 | -4.68 |
| 2025-11-25 | -4.69 |
| 2025-11-24 | -4.76 |
| 2025-11-21 | -3.94 |
| 2025-11-20 | -3.72 |
| 2025-11-19 | -3.69 |
| 2025-11-18 | -3.79 |
| 2025-11-17 | -3.86 |
| 2025-11-14 | -3.66 |
| 2025-11-13 | -3.76 |
| 2025-11-12 | -3.59 |
| 2025-11-11 | -3.66 |
| 2025-11-10 | -3.59 |
| 2025-11-07 | -3.52 |
| 2025-11-06 | -3.80 |
| 2025-11-05 | -3.81 |
| 2025-11-04 | -4.00 |
| 2025-11-03 | -4.04 |
| 2025-10-31 | -4.16 |
| 2025-10-30 | -4.27 |
| 2025-10-29 | -4.26 |
| 2025-10-28 | -4.38 |
| 2025-10-27 | -4.30 |
| 2025-10-24 | -4.00 |
| 2025-10-23 | -3.94 |
| 2025-10-22 | -3.77 |
| 2025-10-21 | -4.10 |
| 2025-10-20 | -4.16 |
| 2025-10-17 | -3.78 |
| 2025-10-16 | -3.79 |
| 2025-10-15 | -3.85 |
| 2025-10-14 | -3.51 |
| 2025-10-13 | -3.65 |
| 2025-10-10 | -3.79 |
| 2025-10-09 | -3.95 |
| 2025-10-08 | -3.56 |
| 2025-10-07 | -3.40 |
| 2025-10-06 | -3.26 |